Summary

Eligibility
for people ages 12 months to 21 years (full criteria)
Location
at Los Angeles, California and other locations
Dates
study started
completion around
Principal Investigator
by Satiro De Oliveira, MD
Headshot of Satiro De Oliveira
Satiro De Oliveira

Description

Summary

This Pediatric MATCH screening and multi-sub-study phase II trial studies how well treatment that is directed by genetic testing works in pediatric patients with solid tumors, non-Hodgkin lymphomas, or histiocytic disorders that have progressed following at least one line of standard systemic therapy and/or for which no standard treatment exists that has been shown to prolong survival. Genetic tests look at the unique genetic material (genes) of patients' tumor cells. Patients with genetic changes or abnormalities (mutations) may benefit more from treatment which targets their tumor's particular genetic mutation, and may help doctors plan better treatment for patients with solid tumors or non-Hodgkin lymphomas.

Official Title

NCI-COG Pediatric MATCH (Molecular Analysis for Therapy Choice) Screening Protocol

Details

Keywords

Eligibility

Locations

Lead Scientist at UCLA

Details

Status
in progress, not accepting new patients
Start Date
Completion Date
(estimated)
Sponsor
National Cancer Institute (NCI)
Links
Sign up for this study
ID
NCT03155620
Phase
Phase 2 research study
Study Type
Interventional
Participants
Expecting 2316 study participants
Last Updated